{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-011915","form_type":"8-K","ticker":"SRZN","cik":"0001824893","company_name":"Surrozen, Inc./DE","filed_at":"2023-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.910582+00:00","generated_at":"2026-06-17T05:58:35.189574+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Surrozen appoints Eric Bjerkholt as Class I director and audit committee member","bullets":["Eric Bjerkholt appointed to board as Class I director effective April 5, 2023.","He will serve on the audit committee.","Bjerkholt is CFO of Chinook Therapeutics; previously CFO of Aimmune, leading its $2.6B sale to Nestle.","Compensation: $35,000 annual retainer, $7,500 audit retainer, initial option grant of 40,000 shares vesting over 36 months.","Standard indemnification agreement entered with Bjerkholt."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-011915","json":"https://secwatch.observer/filing/0000950170-23-011915.json","markdown":"https://secwatch.observer/filing/0000950170-23-011915.md","text":"https://secwatch.observer/filing/0000950170-23-011915.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023011915/0000950170-23-011915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023011915/srzn-20230405.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:58:35.189574+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"692abfa528","claim":"Eric Bjerkholt was appointed as Class I Director at Surrozen, Inc./DE.","evidence_excerpt":"On April 5, 2023, the board of directors of Surrozen, Inc. appointed Eric Bjerkholt to serve as a Class I director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824893/000095017023011915/0000950170-23-011915-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}